Home Newsfeeds JP Morgan Downgrades TuSimple Hldgs to Underweight

JP Morgan Downgrades TuSimple Hldgs to Underweight

JP Morgan analyst Brian Ossenbeck downgrades TuSimple Hldgs (NASDAQ:TSP) from Overweight to Underweight.

byBenzinga Newsdesk

November 1, 2022

1 minute read

JP Morgan analyst Brian Ossenbeck downgrades TuSimple Hldgs (NASDAQ:TSP) from Overweight to Underweight.

Ceridian HCM Holding Q3 EPS $0.20 Beats $0.15 Estimate, Sales $315.60M Miss $417.22M Estimate

By Benzinga Newsdesk

November 2, 4:57 PM

Ceridian HCM Holding (NYSE:CDAY) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.15 by 33.33 percent. This is a 300 percent increase over earnings of $0.05 per share from

CDAY

Autolus Therapeutics To Present Clinical Data Updates At The American Society Of Hematology Annual Meeting 2023 In Two Oral Presentations And Two Poster Presentations

By Benzinga Newsdesk

November 2, 9:13 AM

obe-cel: oral presentation – pooled analysis of the ongoing FELIX Phase Ib/II studyAUTO8: oral presentation of MCARTY Phase I Studyobe-cel: poster presentation - pooled analysis from ALLCAR19 and FELIX Phase Ib studies

AUTL

Don’t Worry ‘Stranger Things’ Fans, Spinoff Series And More Content Coming From Creative Team: Here’s The Details

By Chris Katje

July 6, 6:39 PM

One of the most successful Netflix Inc (NASDAQ: NFLX) original series of all time is coming to an end with a fifth season. The good news is subscribers of the popular streaming platform will see a spinoff series and more work from the creative team behind “Stranger Things.”

AMZN

Imax And Kinepolis Expand Longstanding Partnership With Eight Imax Systems Across Europe And North America

By Happy Mohamed

May 17, 1:01 PM

New Agreement Spans France, Belgium, Spain, the United States, Canada, as well as the First-Ever IMAX Location in Luxembourg CANNES, France, May 17, 2023 /PRNewswire/ -- Kinepolis

IMAX

JP Morgan Downgrades TuSimple Hldgs to Underweight

Related Posts

Ceridian HCM Holding Q3 EPS $0.20 Beats $0.15 Estimate, Sales $315.60M Miss $417.22M Estimate

Autolus Therapeutics To Present Clinical Data Updates At The American Society Of Hematology Annual Meeting 2023 In Two Oral Presentations And Two Poster Presentations

Don’t Worry ‘Stranger Things’ Fans, Spinoff Series And More Content Coming From Creative Team: Here’s The Details

Imax And Kinepolis Expand Longstanding Partnership With Eight Imax Systems Across Europe And North America